Azitra (AZTR) Liabilities and Shareholders Equity (2022 - 2026)

Azitra (AZTR) posted Liabilities and Shareholders Equity of $12.1 million for Q1 2026, up 141.31% on a QoQ basis from $5.0 million in Q4 2025, and up 105.26% year-over-year from $5.9 million in Q1 2025.

Azitra (AZTR) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

Azitra's Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $12.1 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 105.26% year-over-year to $12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.4 million (down 5.64% YoY) and the FY2025 annual result came in at $5.0 million, down 31.71% from the prior year.
  • Liabilities and Shareholders Equity was $12.1 million for Q1 2026 at Azitra, up from $5.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $12.1 million in Q1 2026 and bottomed at $3.9 million in Q2 2024.
  • A 5-year average of $6.8 million and a median of $6.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity sank 60.5% — and 2026, when it surged 105.26%.
  • Azitra's Liabilities and Shareholders Equity stood at $7.2 million in 2022, then fell by 28.63% to $5.1 million in 2023, then surged by 43.85% to $7.4 million in 2024, then tumbled by 31.71% to $5.0 million in 2025, then soared by 141.31% to $12.1 million in 2026.
  • Business Quant data shows AZTR's Liabilities and Shareholders Equity at $12.1 million in Q1 2026, $5.0 million in Q4 2025, and $4.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Nanobiotix 1,792.52 Bn 1,792.46 Bn - 77.11 Mn
2 Akari Therapeutics 999.95 Bn 999.95 Bn - 33.89 Mn
3 BeOne Medicines 475.97 Bn 471.17 Bn 1.35 Bn 8.55 Bn
4 Vertex Pharmaceuticals 124.91 Bn 117.66 Bn 2.59 Bn 26.48 Bn
5 Regeneron Pharmaceuticals 72.31 Bn 63.56 Bn 3.31 Bn 40.87 Bn
6 Belite Bio 62.01 Bn 62.01 Bn - 811.27 Mn
7 Argenx Se 54.23 Bn 49.04 Bn 1.41 Bn 10.03 Bn
8 Alnylam Pharmaceuticals 38.31 Bn 35.30 Bn 959.66 Mn 5.13 Bn
9 Revolution Medicines 36.16 Bn 36.16 Bn - 2.25 Bn
10 Azitra 2.05 Mn 2.05 Mn - 12.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.13 Mn
Dec 31, 2025 5.03 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 3.96 Mn
Mar 31, 2025 5.91 Mn
Dec 31, 2024 7.36 Mn
Sep 30, 2024 9.78 Mn
Jun 30, 2024 3.88 Mn
Mar 31, 2024 6.07 Mn
Dec 31, 2023 5.12 Mn
Sep 30, 2023 7.49 Mn
Jun 30, 2023 9.83 Mn
Dec 31, 2022 7.17 Mn